• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哥伦比亚桑坦德大学医院 32 周以下新生儿代谢性骨病的发生率。

Incidence of metabolic bone disease in neonates under 32 gestational weeks at the Hospital Universitario de Santander in Colombia.

机构信息

Escuela de Medicina, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Colombia.

Departamento de Pediatría, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Colombia.

出版信息

Biomedica. 2024 Mar 31;44(1):35-44. doi: 10.7705/biomedica.6926.

DOI:10.7705/biomedica.6926
PMID:38648348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11185430/
Abstract

INTRODUCTION

Metabolic bone disease of premature infants is a rare complication characterized by a lower mineral content in bone tissue.

OBJECTIVE

To establish the incidence of metabolic bone disease in premature infants and to determine associated risk factors.

MATERIALS AND METHOD

We conducted a descriptive prospective cohort study for one year in all newborns under 32 gestational weeks, or 1,500 g, at the Hospital Universitario de Santander to determine the incidence of metabolic bone disease. We collected demographic data and prenatal histories of the selected patients, and later, we measured serum alkaline phosphatase and serum phosphorus at the third week of birth, having as reference values for diagnosis less than 5.6 mg/dl for the first one and more than 500 UI/L for the second one. We applied statistical tools for data analysis, such as average proportions, dispersion, distribution and association measures, and binomial regression.

RESULTS

From a total of 58 patients, 7 had a diagnosis of metabolic bone disease, with an incidence of 12%. The weight was reported as an independent variable for the development of the disease, being significant in children under 1,160 g, as well as prolonged parenteral nutrition for more than 24 days. When performing the multivariate analysis, low weight and short time of parenteral nutrition appeared as risk factors; in the same way, maternal age below 22 years is associated with a higher relative risk, even more than a newborn weight inferior to 1,160 g.

CONCLUSION

Establishing an early intervention in patients with metabolic bone disease enhancing risk factors, such as low weight and prolonged parenteral nutrition, is critical to prevent severe complications.

摘要

介绍

早产儿代谢性骨病是一种罕见的并发症,其特征是骨组织中的矿物质含量较低。

目的

确定早产儿代谢性骨病的发病率,并确定相关的危险因素。

材料和方法

我们在 Santander 大学医院对所有胎龄小于 32 周或体重小于 1500 克的新生儿进行了为期一年的描述性前瞻性队列研究,以确定代谢性骨病的发病率。我们收集了选定患者的人口统计学数据和产前史,然后在出生后的第三周测量血清碱性磷酸酶和血清磷,将第一个值小于 5.6mg/dl 和第二个值大于 500UI/L 作为诊断参考值。我们应用了数据分析的统计工具,如平均比例、离散度、分布和关联度量以及二项式回归。

结果

在总共 58 名患者中,有 7 名被诊断为代谢性骨病,发病率为 12%。体重被报告为该疾病发展的独立变量,在体重低于 1160 克的儿童中以及在超过 24 天的肠外营养中更为显著。在进行多变量分析时,低体重和短时间的肠外营养似乎是危险因素;同样,母亲年龄低于 22 岁与更高的相对风险相关,甚至超过体重低于 1160 克的新生儿。

结论

对于代谢性骨病患者,确定早期干预并加强低体重和延长肠外营养等危险因素对于预防严重并发症至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbe/11185430/a6c858284432/2590-7379-bio-44-01-6926-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbe/11185430/a6c858284432/2590-7379-bio-44-01-6926-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fbe/11185430/a6c858284432/2590-7379-bio-44-01-6926-gf1.jpg

相似文献

1
Incidence of metabolic bone disease in neonates under 32 gestational weeks at the Hospital Universitario de Santander in Colombia.哥伦比亚桑坦德大学医院 32 周以下新生儿代谢性骨病的发生率。
Biomedica. 2024 Mar 31;44(1):35-44. doi: 10.7705/biomedica.6926.
2
Metabolic bone disease and bone mineral density in very preterm infants.极早产儿的代谢性骨病与骨密度
J Pediatr. 2014 Mar;164(3):499-504. doi: 10.1016/j.jpeds.2013.10.089. Epub 2013 Dec 10.
3
[Osteopenia of prematurity--prophylaxis, diagnostics and treatment].[早产儿骨质减少——预防、诊断与治疗]
Akush Ginekol (Sofiia). 2012;51(7):24-30.
4
[Metabolic Bone Disease of Prematurity in Very Low Birthweight Infants: Retrospective Observational Study].极低出生体重儿的早产代谢性骨病:回顾性观察研究
Acta Med Port. 2019 Aug 1;32(7-8):536-541. doi: 10.20344/amp.10994.
5
Bone Mineral Density According to Dual Energy X-ray Absorptiometry is Associated with Serial Serum Alkaline Phosphatase Level in Extremely Low Birth Weight Infants at Discharge.根据双能X线吸收法测定的骨矿物质密度与极低出生体重儿出院时血清碱性磷酸酶水平的变化有关。
Pediatr Neonatol. 2017 Jun;58(3):251-257. doi: 10.1016/j.pedneo.2016.05.005. Epub 2016 Sep 30.
6
Metabolic Bone Disease of Prematurity: Risk Factors and Associated Short-Term Outcomes.早产儿代谢性骨病:危险因素及相关短期结局。
Nutrients. 2020 Dec 10;12(12):3786. doi: 10.3390/nu12123786.
7
Don't Forget the Bones: Incidence and Risk Factors of Metabolic Bone Disease in a Cohort of Preterm Infants.勿忘骨骼:早产儿队列中代谢性骨病的发生率及相关风险因素。
Int J Mol Sci. 2022 Sep 14;23(18):10666. doi: 10.3390/ijms231810666.
8
Does transient hypothyroxinemia influence metabolic bone disease of prematurity?短暂性甲状腺素血症是否会影响早产儿的代谢性骨病?
J Matern Fetal Neonatal Med. 2013 Dec;26(18):1844-9. doi: 10.3109/14767058.2013.804051. Epub 2013 Jul 26.
9
Early high calcium and phosphorus intake by parenteral nutrition prevents short-term bone strength decline in preterm infants.早期肠外营养中高钙和高磷的摄入可预防早产儿短期骨强度下降。
J Pediatr Gastroenterol Nutr. 2011 Feb;52(2):203-9. doi: 10.1097/MPG.0b013e3181f8b295.
10
Effect of early preventive supplementation with calcium and phosphorus on metabolic bone disease in premature infants.早期预防性补充钙和磷对早产儿代谢性骨病的影响。
BMC Pediatr. 2024 Mar 8;24(1):171. doi: 10.1186/s12887-024-04654-w.

本文引用的文献

1
Early calcium and phosphorus supplementation in VLBW infants to reduce metabolic bone disease of prematurity: a quality improvement initiative.早期补充钙和磷以降低极低出生体重儿代谢性骨病:一项质量改进举措。
BMJ Open Qual. 2022 Aug;11(Suppl 1). doi: 10.1136/bmjoq-2022-001841.
2
Risk factors for metabolic bone disease of prematurity: A meta-analysis.早产儿代谢性骨病的危险因素:一项荟萃分析。
PLoS One. 2022 Jun 13;17(6):e0269180. doi: 10.1371/journal.pone.0269180. eCollection 2022.
3
Expert consensus on clinical management of metabolic bone disease of prematurity (2021).
专家共识:早产儿代谢性骨病的临床管理(2021 年)。
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Aug 15;23(8):761-772. doi: 10.7499/j.issn.1008-8830.2105152.
4
Metabolic Bone Disease of Prematurity: Risk Factors and Associated Short-Term Outcomes.早产儿代谢性骨病:危险因素及相关短期结局。
Nutrients. 2020 Dec 10;12(12):3786. doi: 10.3390/nu12123786.
5
Hypophosphatemia as an Early Metabolic Bone Disease Marker in Extremely Low-Birth-Weight Infants After Prolonged Parenteral Nutrition Exposure.极低出生体重儿长期肠外营养后低磷血症作为早期代谢性骨病标志物。
JPEN J Parenter Enteral Nutr. 2021 Aug;45(6):1268-1274. doi: 10.1002/jpen.2010. Epub 2020 Sep 23.
6
Screening for Metabolic Bone Disease of prematurity.早产儿代谢性骨病的筛查。
Semin Fetal Neonatal Med. 2020 Feb;25(1):101086. doi: 10.1016/j.siny.2020.101086. Epub 2020 Jan 16.
7
History, epidemiology and prevalence of neonatal bone mineral metabolic disorders.新生儿骨代谢紊乱的历史、流行病学和流行情况。
Semin Fetal Neonatal Med. 2020 Feb;25(1):101069. doi: 10.1016/j.siny.2019.101069. Epub 2019 Dec 2.
8
Metabolic Bone Disease in Premature Neonates: An Unmet Challenge.早产儿代谢性骨病:一个未满足的挑战。
J Clin Res Pediatr Endocrinol. 2020 Nov 25;12(4):332-339. doi: 10.4274/jcrpe.galenos.2019.2019.0091. Epub 2019 Nov 1.
9
Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences.早产儿代谢性骨病:病因、识别、预防、治疗和长期后果。
Arch Dis Child Fetal Neonatal Ed. 2019 Sep;104(5):F560-F566. doi: 10.1136/archdischild-2018-316330. Epub 2019 May 11.
10
Risk factors analysis and prevention of metabolic bone disease of prematurity.早产儿代谢性骨病的危险因素分析与预防
Medicine (Baltimore). 2018 Oct;97(42):e12861. doi: 10.1097/MD.0000000000012861.